Gareth Griffiths research projects
Wales Cancer Trials UnitFunding period: 01 October 2008 to 30 September 2013
Clinical & Translational Research Committee (CTRC) Trials Unit Programme Grant
Funding committee: Science Committee
What do we do
The Wales Cancer Trials Unit (WCTU) is dedicated to improving clinical practice through quality research evidence. The WCTU is a one stop shop for a clinical trial, from the basic idea, to producing reliable evidence to change practice. The WCTU is a National Cancer Research Institute (NCRI) accredited and UKCRC registered Clinical Trials Unit and receives core funding from Cancer Research UK and Marie Curie Cancer Care.
Who do we work with
The WCTU, based in Cardiff, works with clinicians and investigators from any cancer area in the UK to develop trial ideas that are then run and coordinated by the WCTU.
Who is on the WCTU team
The WCTU is staffed by a range of experts including Statisticians, Clinicians, Qualitative Researchers, Trial Managers, Data Managers, IT / Programmers, Safety Officers and a Quality Assurance Manager. These staff work with Oncologists, Palliative Care Clinicians and research groups wishing to develop clinical trials or other well designed studies. Proposals for trials are submitted to an appropriate funder, e.g. Cancer Research UK, to consider for funding and if judged to be asking good scientific questions and designed well, it is likely that WCTU will be funded to run the trial. From this point the team at the WCTU will manage all trial procedures working closely with the lead researcher (Chief Investigator).
How do I present my idea to the WCTU
Call us. You will be put in touch with the appropriate scientific lead at the WCTU for your research topic, who will be happy to discuss your idea.
What does the future hold
The WCTU will:
- Build a strong research portfolio spanning cancer patient care from prevention to treatment and post-treatment care incorporating patient-centred, economic and scientific evaluations
- Create a strong research focussed infrastructure to execute studies of high quality, meeting regulatory standards, especially in the fields of cancer therapeutics, primary care and palliative care
- Communicate quality research evidence to the wider cancer research community and monitor impact on cancer outcomes at a national and international level
- Facilitate the involvement of cancer patients, carers and other service users to influence the direction of cancer research